Home / Neoadjuvant vs. adjuvant chemotherapy/immunotherapy in high-risk UTUC: Indications and controversies
Neoadjuvant vs. adjuvant chemotherapy/immunotherapy in high-risk UTUC: Indications and controversies
2021-01-25
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
